Recording Recor Symposium November 2023 at GulfPCR: Renal Denervation 2.0 – ready for Clinical Use?
Recording GulfPCR Symposium 2023
The PARADISE™ system is FDA approved for sale in the United States and is CE marked and approved for sale in markets where the CE mark is accepted.
© 2024 Recor Medical Europe GmbH. All rights reserved. RECOR MEDICAL and PARADISE™ are registered trademarks of Recor Medical, Inc. in the United States and other countries. RADIANCE, the RADIANCE logo, RECOR, HYDROCOOLING, the GPS logo, and SONOWAVE 360 are also trademarks of Recor Medical, Inc.
The PARADISE™ System is covered by US Patent.
Recor Medical, headquartered in Palo Alto, California, USA, a wholly owned subsidiary of Otsuka Medical Devices Co., Ltd. recormedical.eu is Recor Medical, Otsuka Medical Devices Europe GmbH website (the Site). We control and operate this Site from Europe. This Site is intended for use by European residents only and contains information regarding the Paradise™ System, which is approved for sale in the EU and bears a CE mark.
Recor Medical Europe GmbH
Europa-Allee 52 · 60327 Frankfurt · Germany
Amtsgericht Frankfurt am Main: HRB 123214
Chief Executive Officers: Lara Barghout, Michael Jones, Ronan O`Connor
